Michael Morin, left, and David Frazier, right, of Latham & Watkins.

Former researchers at the University of Connecticut's Stem Cell Institute helped test a breakthrough in regenarative medicine. But they did not invent it and should not be listed on patents that describe it, a federal judge has ruled.